Cargando…

Alpha-Synuclein-Specific Naturally Occurring Antibodies Inhibit Aggregation In Vitro and In Vivo

Parkinson’s disease (PD) is associated with motor and non-motor symptoms and characterized by aggregates of alpha-synuclein (αSyn). Naturally occurring antibodies (nAbs) are part of the innate immune system, produced without prior contact to their specific antigen, and polyreactive. The abundance of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Braczynski, Anne K., Sevenich, Marc, Gering, Ian, Kupreichyk, Tatsiana, Agerschou, Emil D., Kronimus, Yannick, Habib, Pardes, Stoldt, Matthias, Willbold, Dieter, Schulz, Jörg B., Bach, Jan-Philipp, Falkenburger, Björn H., Hoyer, Wolfgang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946620/ https://www.ncbi.nlm.nih.gov/pubmed/35327661 http://dx.doi.org/10.3390/biom12030469

Ejemplares similares

Nucleation of α-Synuclein Amyloid Fibrils Induced by Cross-Interaction with β-Hairpin Peptides Derived from Immunoglobulin Light Chains
por: Heid, Laetitia F., et al.
Publicado: (2023)

Opposed Effects of Dityrosine Formation in Soluble and Aggregated α-Synuclein on Fibril Growth
por: Wördehoff, Michael M., et al.
Publicado: (2017)

An engineered monomer binding-protein for α-synuclein efficiently inhibits the proliferation of amyloid fibrils
por: Agerschou, Emil Dandanell, et al.
Publicado: (2019)

Inhibitor and substrate cooperate to inhibit amyloid fibril elongation of α-synuclein
por: Agerschou, Emil Dandanell, et al.
Publicado: (2020)

Extending the functional characteristics of naturally occurring autoantibodies against β-Amyloid, Prion Protein and α-Synuclein
por: Albus, Alexandra, et al.
Publicado: (2018)

β-Hairpin of Islet Amyloid Polypeptide Bound to an Aggregation Inhibitor
por: Mirecka, Ewa A., et al.
Publicado: (2016)

Clustering of human prion protein and α-synuclein oligomers requires the prion protein N-terminus
por: Rösener, Nadine S., et al.
Publicado: (2020)

A So-Far Overlooked Secondary Conformation State in the Binding Mode of SARS-CoV-2 Spike Protein to Human ACE2 and Its Conversion Rate Are Crucial for Estimating Infectivity Efficacy of the Underlying Virus Variant
por: Sevenich, Marc, et al.
Publicado: (2022)

The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson’s Disease
por: Albus, Alexandra, et al.
Publicado: (2023)

CK1BP Reduces α-Synuclein Oligomerization and Aggregation Independent of Serine 129 Phosphorylation
por: Elsholz, Lea, et al.
Publicado: (2021)

A β-Wrapin Targeting the N-Terminus of α-Synuclein Monomers Reduces Fibril-Induced Aggregation in Neurons
por: Szegő, Éva M., et al.
Publicado: (2021)

The role of heat shock proteins in preventing amyloid toxicity
por: Törner, Ricarda, et al.
Publicado: (2022)

Structural basis for the inhibition of IAPP fibril formation by the co-chaperonin prefoldin
por: Törner, Ricarda, et al.
Publicado: (2022)

The Importance of Epigallocatechin as a Scaffold for Drug Development against Flaviviruses
por: Coronado, Mônika A., et al.
Publicado: (2023)

Atomic Resolution Insights into pH Shift Induced Deprotonation Events in LS-Shaped Aβ(1–42) Amyloid Fibrils
por: Becker, Nina, et al.
Publicado: (2023)

Discovery of All-d-Peptide Inhibitors of SARS-CoV-2 3C-like Protease
por: Eberle, Raphael J., et al.
Publicado: (2023)

Patients with isolated REM-sleep behavior disorder have elevated levels of alpha-synuclein aggregates in stool
por: Schaffrath, Anja, et al.
Publicado: (2023)

Solution structure of the X4 protein coded by the SARS related coronavirus reveals an immunoglobulin like fold and suggests a binding activity to integrin I domains
por: Hänel, Karen, et al.
Publicado: (2005)

α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
por: Bartels, Tim, et al.
Publicado: (2011)

Quantitative detection of α-Synuclein and Tau oligomers and other aggregates by digital single particle counting
por: Blömeke, Lara, et al.
Publicado: (2022)

Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia
por: Kronimus, Yannick, et al.
Publicado: (2016)

Tau protein aggregation associated with SARS-CoV-2 main protease
por: Eberle, Raphael Josef, et al.
Publicado: (2023)

The Mitochondrial Chaperone Protein TRAP1 Mitigates α-Synuclein Toxicity
por: Butler, Erin K., et al.
Publicado: (2012)

Data describing the solution structure of the WW3* domain from human Nedd4-1
por: Panwalkar, Vineet, et al.
Publicado: (2016)

The Aggregation of Huntingtin and α-Synuclein
por: Chánez-Cárdenas, María Elena, et al.
Publicado: (2012)

Monitoring α-synuclein aggregation
por: Estaun-Panzano, Juan, et al.
Publicado: (2023)

Structural insights from lipid-bilayer nanodiscs link α-Synuclein membrane-binding modes to amyloid fibril formation
por: Viennet, Thibault, et al.
Publicado: (2018)

Stabilization of Monomeric Tau Protein by All D-Enantiomeric Peptide Ligands as Therapeutic Strategy for Alzheimer’s Disease and Other Tauopathies
por: Altendorf, Tim, et al.
Publicado: (2023)

Wild-Type α-Synuclein and Variants Occur in Different Disordered Dimers and Pre-Fibrillar Conformations in Early Stage of Aggregation
por: Guzzo , Adrien, et al.
Publicado: (2022)

Activated Endolysosomal Cation Channel TRPML1 Facilitates Maturation of α-Synuclein-Containing Autophagosomes
por: Pollmanns, Maike R., et al.
Publicado: (2022)

SUMOylation of Alpha-Synuclein Influences on Alpha-Synuclein Aggregation Induced by Methamphetamine
por: Zhu, Lin-nan, et al.
Publicado: (2018)

Acceleration of α-Synuclein Aggregation by Exosomes
por: Grey, Marie, et al.
Publicado: (2015)

Alpha-Synuclein Aggregation in Parkinson's Disease
por: Srinivasan, E., et al.
Publicado: (2021)

Aggregation and neurotoxicity of recombinant α-synuclein aggregates initiated by dimerization
por: Roostaee, Alireza, et al.
Publicado: (2013)

In Vitro and In Vivo Efficacies of the Linear and the Cyclic Version of an All-d-Enantiomeric Peptide Developed for the Treatment of Alzheimer’s Disease
por: Schemmert, Sarah, et al.
Publicado: (2021)

Fibril core regions in engineered α-synuclein dimer are crucial for blocking of fibril elongation
por: Schulz, Celina M., et al.
Publicado: (2023)

Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein
por: Elfarrash, Sara, et al.
Publicado: (2021)

Unveiling a Selective Mechanism for the Inhibition of α-Synuclein Aggregation by β-Synuclein
por: Leitao, Andre, et al.
Publicado: (2018)

Synuclein Family Members Prevent Membrane Damage by Counteracting α-Synuclein Aggregation
por: Scheibe, Christian, et al.
Publicado: (2021)

Sumoylation inhibits α-synuclein aggregation and toxicity
por: Krumova, Petranka, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_to83fg6an9fvo96ad1kinmk72m